ABPA relapse after discontinuation of omalizumab
Sign Up to like & getrecommendations! Published in 2020 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2020.2223
Abstract: Allergic bronchopulmonary aspergillosis (ABPA) often complicates severe asthma (SA). Omalizumab (OMA) has been successfully employed in the treatment of ABPA, in addition to systemic corticosteroids and itraconazole. We report two cases of patients with allergic… read more here.
Keywords: abpa relapse; omalizumab; relapse discontinuation; abpa ... See more keywords